Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02817997 · ClinicalTrials.gov registry record
International Registry for Patients With Castleman Disease
A clinical trial of Castleman's Disease and Castleman Disease, sponsored by University of Pennsylvania.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 1
- Study location
NCT02817997 is a study of Castleman's Disease and Castleman Disease that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 1,000 participants, above the 761-participant average among 3 other Castleman's Disease trials with a reported enrollment target (31% higher). The trial reports 1 study location across 1 state.
The verdict
NCT02817997, a study of Castleman's Disease and Castleman Disease, is actively recruiting participants, sponsored by University of Pennsylvania.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to collect clinical, laboratory, and patient survey data from patients with Castleman disease to improve understanding, diagnosis, and treatment of the disease. Funding source - FDA OOPD.
Conditions Studied
Study Locations (1)
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2016-10 |
| Est. Completion | 2027-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02817997
The ClinicalTrials.gov registry entry for NCT02817997 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 761-participant average among 3 other Castleman's Disease trials with a reported enrollment target (31% higher). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 9 conditions, with Castleman's Disease appearing as the primary indexed condition, and to 0 interventions.
NCT02817997 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT02817997 about?
NCT02817997 is a clinical study titled "International Registry for Patients With Castleman Disease". The purpose of this study is to collect clinical, laboratory, and patient survey data from patients with Castleman disease to improve understanding, diagnosis, and treatment of the disease. Funding source - FDA OOPD.
What is the current status of trial NCT02817997?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2016-10. Estimated completion is 2027-09.
What conditions does trial NCT02817997 study?
This clinical trial studies the following conditions: Castleman's Disease, Castleman Disease, Giant Lymph Node Hyperplasia, Angiofollicular Lymph Hyperplasia, Angiofollicular Lymph Node Hyperplasia.
Who is sponsoring clinical trial NCT02817997?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02817997 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Castleman's Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Registry for Adults With Plasma Cell Disorders (PCD's)
RECRUITING
-
Molecular Characterization of Viral-associated Tumors, Tumors Occurring in the Setting of HIV or Other Immune Disorders and Castleman Disease
RECRUITING
-
A Study to Provide RoActemra/Actemra (Tocilzumab) to Patients With Multicentric Castleman's Disease Who Demonstrated Benefit From Previous RoActemra/Actemra Treatment
COMPLETED · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.